Literature DB >> 11549509

Expression of the cell cycle proteins p21, p27, and pRb in clear cell renal cell carcinoma and their prognostic significance.

A Haitel1, H G Wiener, B Neudert, M Marberger, M Susani.   

Abstract

OBJECTIVES: To determine whether p21, p27, and pRb can predict disease progression in clear cell renal cell carcinoma.
METHODS: The expression of three negative regulators of the cell cycle, the retinoblastoma gene product (pRb), the WAF1/Cip1 gene product (p21), and the Kip1 gene product (p27), was investigated by immunohistochemistry on paraffin sections from 104 formalin-fixed clear cell carcinoma specimens and related to p53 overexpression, the clinicopathologic parameters, and survival.
RESULTS: pRb expression was not associated with tumor stage, but the correlation with p27 and p21 positivity was statistically significant (r = 0.26, P = 0.008 and r = 0.3, P = 0.002, respectively). Tumors representing p53 overexpression showed a higher pRb labeling index compared with p53-negative tumors (P = 0.0004). p21 protein expression correlated significantly with p27 positivity (r = 0.2, P = 0.04) and was associated with p53 overexpression (P = 0.0005), but did not correlate with tumor stage or grade. No association could be found between p27 positivity and tumor grade, tumor stage, or p53 overexpression. In univariate survival analysis, an increased pRb positivity (P = 0.002) and a low p27 expression (P = 0.0001) predicted a poor outcome, especially if combined with p53 overexpression (P = 0.004 and P = 0.0002, respectively). p21 did not give any prognostic information. Moreover, in multivariate analysis, pRb and p27 were revealed to be statistically significant.
CONCLUSIONS: The results of our study indicate that in clear cell renal cell carcinoma, the cell cycle proteins p27 and pRb are powerful and independent prognostic factors and that p21 has no predictive value.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11549509     DOI: 10.1016/s0090-4295(01)01188-8

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  13 in total

1.  Targeted therapy in renal cancer.

Authors:  Tanya B Dorff; Amir Goldkorn; David I Quinn
Journal:  Ther Adv Med Oncol       Date:  2009-11       Impact factor: 8.168

2.  Loss of p27(Kip1) CDKI is a predictor of poor recurrence-free and cancer-specific survival in patients with renal cancer.

Authors:  Ambrosi Pertia; David Nikoleishvili; Omar Trsintsadze; Nino Gogokhia; Laurent Managadze; Archil Chkhotua
Journal:  Int Urol Nephrol       Date:  2007-02-20       Impact factor: 2.370

3.  Biological significance of p27 and Skp2 expression in renal cell carcinoma. A systematic analysis of primary and metastatic tumour tissues using a tissue microarray technique.

Authors:  Cord Langner; Reinhard von Wasielewski; Manfred Ratschek; Peter Rehak; Richard Zigeuner
Journal:  Virchows Arch       Date:  2004-10-28       Impact factor: 4.064

4.  p21 and p27 immunoexpression in gastric well differentiated endocrine tumors (ECL-cell carcinoids).

Authors:  Basak Doganavsargil; Banu Sarsik; Fatma Secil Kirdok; Ahmet Musoglu; Muge Tuncyurek
Journal:  World J Gastroenterol       Date:  2006-10-21       Impact factor: 5.742

5.  Genetic polymorphisms of p21 and risk of second primary malignancy in patients with index squamous cell carcinoma of the head and neck.

Authors:  Dapeng Lei; Erich M Sturgis; Zhensheng Liu; Mark E Zafereo; Qingyi Wei; Guojun Li
Journal:  Carcinogenesis       Date:  2009-12-02       Impact factor: 4.944

6.  Immunoreactivity of p27(Kip1), cyclin D3, and Ki67 in conventional renal cell carcinoma.

Authors:  Ambrosi Pertia; David Nikoleishvili; Omar Trsintsadze; Nino Gogokhia; Laurent Managadze; Archil Chkhotua
Journal:  Int Urol Nephrol       Date:  2008-08-05       Impact factor: 2.370

7.  The expression of Cullin1 is increased in renal cell carcinoma and promotes cancer cell proliferation, migration, and invasion.

Authors:  Ji-Gen Ping; Fei Wang; Jin-Xian Pu; Ping-Fu Hou; Yan-Su Chen; Jin Bai; Jun-Nian Zheng
Journal:  Tumour Biol       Date:  2016-07-23

8.  The expression of Eg5 predicts a poor outcome for patients with renal cell carcinoma.

Authors:  Dingqi Sun; Jiaju Lu; Kejia Ding; Dongbin Bi; Zhihong Niu; Qingwei Cao; Jie Zhang; Sentai Ding
Journal:  Med Oncol       Date:  2013-02-01       Impact factor: 3.064

9.  Expression and altered subcellular localization of the cyclin-dependent kinase inhibitor p27Kip1 in hepatocellular carcinoma.

Authors:  Ke-Jun Nan; Zhao Jing; Ling Gong
Journal:  World J Gastroenterol       Date:  2004-05-15       Impact factor: 5.742

10.  Cytoplasmic sequestration of p27 via AKT phosphorylation in renal cell carcinoma.

Authors:  Jinhee Kim; Eric Jonasch; Angela Alexander; John D Short; Shengli Cai; Sijin Wen; Dimitra Tsavachidou; Pheroze Tamboli; Bogdan A Czerniak; Kim Anh Do; Kevin J Wu; Laura A Marlow; Christopher G Wood; John A Copland; Cheryl Lyn Walker
Journal:  Clin Cancer Res       Date:  2009-01-01       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.